Eastwood Bio-Medical Canada Inc
XTSX:EBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Eastwood Bio-Medical Canada Inc
Cost of Revenue
Eastwood Bio-Medical Canada Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Eastwood Bio-Medical Canada Inc
XTSX:EBM
|
Cost of Revenue
-CA$223.5k
|
CAGR 3-Years
18%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cost of Revenue
-$3.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-1%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cost of Revenue
-CA$204.4m
|
CAGR 3-Years
30%
|
CAGR 5-Years
18%
|
CAGR 10-Years
-27%
|
|
|
Cronos Group Inc
TSX:CRON
|
Cost of Revenue
-$83.8m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-90%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cost of Revenue
-CA$242.4m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-90%
|
|
Eastwood Bio-Medical Canada Inc
Glance View
Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients. The Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. The firm's licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D for the development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55, a sedative and tension relief, Eleotin Zn330, which is involved in tissue formation and metabolism; Eleotin Bentley, which is used to promote healthy glucose levels, and Eleotin LBM, which is recommended for hypertension relief.
See Also
What is Eastwood Bio-Medical Canada Inc's Cost of Revenue?
Cost of Revenue
-223.5k
CAD
Based on the financial report for Jan 31, 2026, Eastwood Bio-Medical Canada Inc's Cost of Revenue amounts to -223.5k CAD.
What is Eastwood Bio-Medical Canada Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
17%
Over the last year, the Cost of Revenue growth was 8%. The average annual Cost of Revenue growth rates for Eastwood Bio-Medical Canada Inc have been 18% over the past three years , 17% over the past five years .
